在宅ヘルスケア市場レポート：製品、サービス、適応症、地域別、2024年～2032年

世界の在宅ヘルスケア市場規模は2023年に3,922億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率（CAGR）は7.87％を示し、2032年には7,917億米ドルに達すると予測しています。慢性疾患の増加、医療技術の進歩、有利な政府政策の実施、個別化された費用対効果の高いヘルスケアサービスへの需要の高まりなどが、市場を後押しする主な要因となっています。

在宅ヘルスケアとは、快適な自宅で個人に提供される医療・非医療サービスを指します。病気や怪我、手術からの回復、慢性疾患の管理、加齢に伴う課題などに直面している個人を支援します。一般的には、熟練した看護ケア、理学療法、作業療法、投薬管理、創傷ケア、入浴、着替え、食事の準備などの日常生活活動の支援が含まれます。在宅医療は患者の自立を促し、生活の質を向上させ、住み慣れた環境の中で個別化されたきめ細かなケアを受けることができます。さらに、在宅ヘルスケアは費用対効果が高く便利なオプションであり、個々のニーズに合わせてカスタマイズされるため、最適なサポートと患者の高い満足度を保証します。

市場は主に慢性疾患の増加によって牽引されています。さらに、人口の増加やいくつかの病気にかかりやすい老年人口の増加は、自宅で快適に医療や支援を受けることを好むため、個別化された継続的な在宅ヘルスケアサービスの需要が高まっています。さらに、医療技術や遠隔医療ソリューションの数多くの技術的進歩により、医療提供者が自宅で患者を遠隔監視・管理することが容易になったことも、成長を促す大きな要因となっています。これに加えて、在宅ヘルスケアは病院の再入院を減らし、医療施設の負担を軽減することで費用対効果の高いソリューションを提供し、市場の成長を加速させています。これに加え、最近のコロナウイルス感染症（COVID-19）の大流行が、社会的距離を置く規範のために在宅医療の採用を加速させ、曝露リスクを最小限に抑え、安全を確保するため、市場成長を促進しています。

在宅ヘルスケア市場の動向と促進要因：

慢性疾患の流行

糖尿病、心臓病、慢性呼吸器疾患、神経疾患などの慢性疾患の流行は、世界中でますます一般的になっています。これらの疾患は長期的な管理、頻繁なモニタリング、個別ケアを必要とすることが多く、市場成長に影響を与えています。さらに、在宅医療サービスは慢性疾患患者のニーズに対応するのに適しており、在宅でケアを受けることで、患者は継続的なモニタリング、投薬管理、日常生活動作のサポートなどの恩恵を受けることができます。また、患者が病状を効果的に管理できるよう、個別化された治療計画、リハビリテーション・サービス、教育も提供されるため、市場の成長が加速します。このほか、慢性疾患患者は頻繁な経過観察や継続的なサポートを必要とすることが多いため、病院やヘルスケア施設の負担を軽減することができ、市場の成長を後押しします。また、在宅ケアを提供することで、医療資源を急性かつ重篤な患者により効果的に割り当てることができるため、市場の成長を後押ししています。さらに、在宅ケアへのシフトは患者の転帰と生活の質を改善し、コスト抑制とより効率的なヘルスケア提供に貢献するため、市場の見通しは明るいです。

医療技術の進歩

医療技術の進歩は在宅ヘルスケア市場に大きな影響を与えており、患者の自宅で医療サービスを提供する方法を変革しています。さらに、遠隔監視装置の普及により、医療提供者は離れた場所から血圧、心拍数、血糖値などの患者のバイタルサインを追跡できるようになり、タイムリーな介入と慢性疾患のより良い管理が可能になり、市場成長に影響を与えています。さらに、スマートピルディスペンサー、スマートベッド、遠隔制御医療機器などのモノのインターネット（IoT）デバイスの統合により、患者の安全性と利便性が向上し、治療計画の遵守が保証され、有害事象のリスクが低減されることも、大きな成長促進要因となっています。このほか、患者記録のデジタル化が進むことで、ヘルスケアプロバイダー間で医療情報のシームレスな共有が可能になり、ケアコーディネーションが強化され、患者の健康履歴を全体的に把握できるようになるため、市場の成長が加速します。

有利な政府政策の実施

各国政府は、在宅ケアの潜在的な利点に着目し、その導入を促進するための支援政策を導入しています。さらに、多くの政府が在宅ケアの拡大を奨励し、特にサービスが行き届いていない地域における患者のアクセスを改善するために、在宅医療サービスを提供するヘルスケアプロバイダーや機関に財政的インセンティブや補助金を提供しており、これが市場成長に影響を与えています。さらに、政府は在宅医療提供者に対する規制障壁やライセンス要件を緩和しており、在宅医療提供者の事業運営やサービス提供を容易にし、新規参入企業の市場参入を促進していることも、市場成長を促す大きな要因となっています。これに加え、ヘルスケア償還政策が在宅医療サービスの適用を含むように改訂され、患者にとってより手頃な価格となっていることも、特に高齢者や慢性疾患を持つ人々の間で在宅医療の需要を加速させており、市場成長を後押ししています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 世界の在宅ヘルスケア市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• 治療製品
  • 市場動向
  • 市場予測
• 検査、スクリーニング、モニタリング製品
  • 市場動向
  • 市場予測
• モビリティケア製品
  • 市場動向
  • 市場予測

第7章 市場内訳：サービス別

• 介護サービス
  • 市場動向
  • 市場予測
• リハビリテーション
  • 市場動向
  • 市場予測
• ホスピス＆緩和ケア
  • 市場動向
  • 市場予測
• 未熟練者ケア
  • 市場動向
  • 市場予測
• 呼吸療法
  • 市場動向
  • 市場予測
• 輸液療法
  • 市場動向
  • 市場予測
• 妊娠ケア
  • 市場動向
  • 市場予測

第8章 市場内訳：適応症別

• がん
  • 市場動向
  • 市場予測
• 呼吸器疾患
  • 市場動向
  • 市場予測
• 運動障害
  • 市場動向
  • 市場予測
• 心血管疾患と高血圧症
  • 市場動向
  • 市場予測
• 妊娠
  • 市場動向
  • 市場予測
• 創傷ケア
  • 市場動向
  • 市場予測
• 糖尿病
  • 市場動向
  • 市場予測
• 聴覚障害
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：地域別

• 北米
  • 米国
    • 市場動向
    • 市場予測
  • カナダ
    • 市場動向
    • 市場予測
• アジア太平洋
  • 中国
    • 市場動向
    • 市場予測
  • 日本
    • 市場動向
    • 市場予測
  • インド
    • 市場動向
    • 市場予測
  • 韓国
    • 市場動向
    • 市場予測
  • オーストラリア
    • 市場動向
    • 市場予測
  • インドネシア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• 欧州
  • ドイツ
    • 市場動向
    • 市場予測
  • フランス
    • 市場動向
    • 市場予測
  • 英国
    • 市場動向
    • 市場予測
  • イタリア
    • 市場動向
    • 市場予測
  • スペイン
    • 市場動向
    • 市場予測
  • ロシア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• ラテンアメリカ
  • ブラジル
    • 市場動向
    • 市場予測
  • メキシコ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • A&D Company Limited
  • Addus HomeCare Corporation
  • Amedisys Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Fresenius Medical Care AG & Co. KGaA
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Medline Industries LP
  • OMRON Healthcare Inc.（Omron Corporation）
  • ResMed Inc.

List of Figures

• Figure 1: Global: Home Healthcare Market: Major Drivers and Challenges
• Figure 2: Global: Home Healthcare Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Home Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Home Healthcare Market: Breakup by Product (in %), 2023
• Figure 5: Global: Home Healthcare Market: Breakup by Service (in %), 2023
• Figure 6: Global: Home Healthcare Market: Breakup by Indication (in %), 2023
• Figure 7: Global: Home Healthcare Market: Breakup by Region (in %), 2023
• Figure 8: Global: Home Healthcare (Therapeutic Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Home Healthcare (Therapeutic Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Home Healthcare (Testing, Screening, and Monitoring Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Home Healthcare (Testing, Screening, and Monitoring Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Home Healthcare (Mobility Care Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Home Healthcare (Mobility Care Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Home Healthcare (Skilled Nursing) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Home Healthcare (Skilled Nursing) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Home Healthcare (Rehabilitation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Home Healthcare (Rehabilitation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Home Healthcare (Hospice & Palliative Care) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Home Healthcare (Hospice & Palliative Care) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Home Healthcare (Unskilled Care) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Home Healthcare (Unskilled Care) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Home Healthcare (Respiratory Therapy) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Home Healthcare (Respiratory Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Home Healthcare (Infusion Therapy) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Home Healthcare (Infusion Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: Global: Home Healthcare (Pregnancy Care) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: Global: Home Healthcare (Pregnancy Care) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Global: Home Healthcare (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Global: Home Healthcare (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Global: Home Healthcare (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Global: Home Healthcare (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Global: Home Healthcare (Movement Disorders) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Global: Home Healthcare (Movement Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: Global: Home Healthcare (Cardiovascular Diseases & Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: Global: Home Healthcare (Cardiovascular Diseases & Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Global: Home Healthcare (Pregnancy) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Global: Home Healthcare (Pregnancy) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: Global: Home Healthcare (Wound Care) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: Global: Home Healthcare (Wound Care) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Global: Home Healthcare (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Global: Home Healthcare (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Global: Home Healthcare (Hearing Disorders) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Global: Home Healthcare (Hearing Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Global: Home Healthcare (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Global: Home Healthcare (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: North America: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: North America: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: United States: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: United States: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Canada: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Canada: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: Asia-Pacific: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: Asia-Pacific: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: China: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: China: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Japan: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Japan: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: India: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: India: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: South Korea: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: South Korea: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Australia: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Australia: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Indonesia: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Indonesia: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Others: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Others: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Europe: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Europe: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Germany: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Germany: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: France: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: France: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 74: United Kingdom: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 75: United Kingdom: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 76: Italy: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 77: Italy: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 78: Spain: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 79: Spain: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 80: Russia: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 81: Russia: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 82: Others: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 83: Others: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 84: Latin America: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 85: Latin America: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 86: Brazil: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 87: Brazil: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 88: Mexico: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 89: Mexico: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 90: Others: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 91: Others: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 92: Middle East and Africa: Home Healthcare Market: Sales Value (in Million US$), 2018 & 2023
• Figure 93: Middle East and Africa: Home Healthcare Market: Breakup by Country (in %), 2023
• Figure 94: Middle East and Africa: Home Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 95: Global: Home Healthcare Industry: SWOT Analysis
• Figure 96: Global: Home Healthcare Industry: Value Chain Analysis
• Figure 97: Global: Home Healthcare Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Home Healthcare Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Home Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Home Healthcare Market Forecast: Breakup by Service (in Million US$), 2024-2032
• Table 4: Global: Home Healthcare Market Forecast: Breakup by Indication (in Million US$), 2024-2032
• Table 5: Global: Home Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Home Healthcare Market: Competitive Structure
• Table 7: Global: Home Healthcare Market: Key Players

Abstract

The global home healthcare market size reached US$ 392.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 791.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.87% during 2024-2032. The increasing incidences of chronic diseases, several advancements in medical technology, the implementation of favorable government policies, and the escalating demand for personalized and cost-effective healthcare services are some of the major factors propelling the market.

Home healthcare refers to medical and non-medical services provided to individuals in the comfort of their own homes. It assists individuals who may be recovering from an illness, injury, or surgery, managing chronic conditions, or facing challenges due to age-related issues. It typically includes skilled nursing care, physical and occupational therapy, medication management, wound care, and assistance with daily living activities such as bathing, dressing, and meal preparation. It promotes independence and improve the quality of life for patients and allows them to remain in familiar surroundings while receiving personalized and attentive care. Additionally, home healthcare is cost-effective and convenient option and are customized to meet individual needs, ensuring optimal support and a higher level of patient satisfaction.

The market is primarily driven by the growing incidences of chronic ailments. Additionally, the increasing population and the growing geriatric populations susceptible to several diseases prefer to receive medical care and assistance in the comfort of their homes, thus escalating the demand for personalized and continuous healthcare services at home. Moreover, numerous technological advancements in medical technology and telehealth solutions made it easier for healthcare providers to remotely monitor and manage patients in their homes represents another major growth-inducing factor. Besides this, home healthcare offers cost-effective solutions by reducing hospital readmissions and easing the burden on healthcare facilities, thus accelerating the market growth. Along with this, the recent onset of the coronavirus disease (COVID-19) pandemic accelerated the adoption of home-based care, due to social distancing norms, minimizes exposure risks, and ensures safety thus propelling the market growth.

Home Healthcare Market Trends/Drivers:

The prevalence of chronic ailments

The prevalence of chronic diseases such as diabetes, heart disease, chronic respiratory conditions, and neurological disorders, are becoming increasingly common across the globe. These conditions often require long-term management, frequent monitoring, and personalized care, thus influencing market growth. Moreover, home healthcare services are well-suited to address the needs of patients with chronic diseases by receiving care at home, patients can benefit from continuous monitoring, medication management, and support with activities of daily living which represents another major growth-inducing factor. It also offers personalized treatment plans, rehabilitation services, and education to help patients manage their conditions effectively, thus accelerating market growth. Besides this, it can reduce the burden on hospitals and healthcare facilities, as patients with chronic diseases often require frequent follow-up visits and ongoing support, thus augmenting the market growth. Also, by providing care at home, healthcare resources can be better allocated to patients with acute and critical conditions which is propelling the market growth. Furthermore, the shift toward home-based care improves patient outcomes and quality of life and contributes to cost containment and more efficient healthcare delivery, creating a positive market outlook.

Several advancements in medical technologies

The increasing advancements in medical technology are significantly impacting the home healthcare market, transforming the way healthcare services are delivered to patients at their homes. Additionally, the widespread adoption of remote monitoring devices allow healthcare providers to track patients' vital signs, such as blood pressure, heart rate, and blood glucose levels, from a distance, allows timely interventions and better management of chronic conditions, thus influencing the market growth. Moreover, the integration of the Internet of Things (IoT) devices, such as smart pill dispensers, smart beds, and remote-controlled medical equipment, enhance patient safety and convenience, ensuring adherence to treatment plans and reducing the risk of adverse events, represents another major growth-inducing factor. Besides this, the increasing digitization of patient records allows seamless sharing of medical information between healthcare providers, enhancing care coordination and enabling a holistic view of the patient's health history, thus accelerating market growth.

The implementation of favorable government policies

The governments are transforming the potential benefits of home-based care and introducing supportive policies to promote its adoption. Additionally, numerous governments are providing financial incentives and subsidies to healthcare providers and agencies offering home healthcare services to encourage the expansion of home-based care and to improve access for patients, especially in underserved areas, which are influencing the market growth. Moreover, governments are easing regulatory barriers and licensing requirements for home healthcare providers, making it easier for them to operate and offer their services facilitating the entry of new players into the market, representing another major growth-inducing factor. Besides this, the healthcare reimbursement policies are revised to include coverage for home healthcare services, making it more affordable for patients, which is accelerating the demand for home healthcare, particularly among the geriatric population and those with chronic conditions is propelling the market growth.

Home Healthcare Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global home healthcare market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, service and indication.

Breakup by Product:

Therapeutic Products

Testing, Screening, and Monitoring Products

Mobility Care Products

Therapeutic products represent the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes therapeutic products, testing, screening, and monitoring products, and mobility care products. According to the report, therapeutic products accounted for the largest market share.

Therapeutic products encompass several medical devices, equipment, and supplies designed to aid in the treatment and management of various health conditions at home. These products include mobility aids such as wheelchairs and walking aids, respiratory devices such as oxygen concentrators and nebulizers, and wound care products including dressings and wound healing agents, thus influencing the market growth. Additionally, therapeutic monitoring devices, such as blood glucose meters and blood pressure monitors, are essential in managing chronic conditions and promoting proactive health management, thus augmenting the market growth.

Moreover, advancements in therapeutic product technology have led to user-friendly designs, portability, and increased effectiveness, further fueling their popularity among patients and caregivers representing another major growth-inducing factor. Besides this, the growing geriatric population and prevalence of chronic diseases are accelerating the adoption of therapeutic products, ensuring improved patient outcomes and better quality of life. Along with this, the inclination toward therapeutic products due to their ability to empower patients with greater independence and control over their healthcare, and offer patients with essential medical care without the need for frequent visits to healthcare facilities are propelling the market growth.

Breakup by Service:

Skilled Nursing

Rehabilitation Therapy

Hospice & Palliative Care

Unskilled Care

Respiratory Therapy

Infusion Therapy

Pregnancy Care

Skilled nursing holds the largest share of the market

A detailed breakup and analysis of the market based on the service has also been provided in the report. This includes skilled nursing, rehabilitation therapy, hospice & palliative care, unskilled care, respiratory therapy, infusion therapy, and pregnancy care. According to the report, skilled nursing accounted for the largest market share.

Skilled nursing is emerging as the dominant service in the home healthcare market. This specialized form of care is provided by trained and licensed nurses who offer comprehensive medical support to patients in the comfort of their homes. It encompasses several healthcare tasks, including wound care, medication management, intravenous therapy, and post-surgical care, thus influencing the market growth.

Additionally, the growing geriatric population and the rising prevalence of chronic illnesses is escalating the demand for skilled nursing services, as patients with complex medical conditions seek personalized and continuous care, thus accelerating the market growth. Also, skilled nursing at home allows patients to avoid hospital stays and reduce the risk of infections, while also providing convenience and comfort during their recovery process.

Breakup by Indication:

Cancer

Respiratory Diseases

Movement Disorders

Cardiovascular Diseases & Hypertension

Pregnancy

Wound Care

Diabetes

Hearing Disorders

Others

Diabetes presently accounts for the largest market share

A detailed breakup and analysis of the market based on the indication has also been provided in the report. These includes cancer, respiratory diseases, movement disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and others. According to the report, diabetes accounted for the largest market share.

Diabetes is emerging as a dominant indication driving the growth of the home healthcare market. Additionally, the increasing incidences of diabetes are escalating the demand for home-based care for diabetic patients, thus influencing market growth. Managing diabetes requires continuous monitoring of blood glucose levels, medication adherence, lifestyle modifications, and regular follow-up with healthcare professionals. Home healthcare offers a convenient and personalized approach to address these needs.

Home-based diabetes care enables patients to receive timely interventions, education, and support in the comfort of their homes, leading to improved disease management and patient outcomes. Additionally, several advancements in medical technology, such as glucose monitoring devices and telehealth solutions, further facilitate remote monitoring and consultation, enhancing the effectiveness of home-based diabetes care. Furthermore, the cost-effectiveness for diabetic patients is particularly appealing, as it reduces the burden on healthcare facilities and minimizes hospital readmissions.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is currently dominating the home healthcare market, holding the largest share due to the growing geriatric population, rising prevalence of chronic diseases, and advanced healthcare infrastructure driving the demand for home-based healthcare services. Additionally, technological advancements in medical devices and telehealth solutions is further accelerating the adoption of home healthcare in North America.

In Europe, the market is experiencing significant growth due to the growing geriatric population, and the increasing healthcare costs leading to governments and healthcare providers to focus on home-based care as a cost-effective and patient-centric solution. Furthermore, favourable government policies and reimbursement support are encouraging the expansion of home healthcare services across Europe.

The Asia Pacific market is witnessing rapid growth due to its growing population, rising awareness of home-based care options, improving healthcare infrastructure, and an increase in chronic diseases, which are escalating the demand for accessible and personalized healthcare services at home.

Competitive Landscape:

Nowadays, key players in the home healthcare market are implementing several strategies to strengthen their position and maintain a competitive edge. They are expanding their range of services to cater to a broader spectrum of patient needs including offering a comprehensive suite of medical, nursing, rehabilitation, and personal care services at home. Moreover, key players are investing in advanced medical technology, remote monitoring devices, telehealth platforms, and mobile health applications to enhance the quality of care, improve patient outcomes, and facilitate remote consultations. Besides this, several companies are prioritizing patient-centric care by customizing services to individual needs, providing personalized treatment plans, and actively involving patients and their families in care decisions. Furthermore, key players are building a robust network of skilled healthcare professionals, including nurses, therapists, and caregivers, to ensure seamless and efficient delivery of services. They are also establishing a strong brand identity and implementing effective marketing strategies to help companies create awareness, build reputation, and attract new patients.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

A&D Company Limited

Addus HomeCare Corporation

Amedisys Inc.

B. Braun Melsungen AG

Baxter International Inc.

Becton Dickinson and Company

Fresenius Medical Care AG & Co. KGaA

Invacare Corporation

Koninklijke Philips N.V.

McKesson Corporation

Medline Industries LP

OMRON Healthcare Inc. (Omron Corporation) and ResMed Inc.

Recent Developments:

Baxter International Inc. made an investment in Medically Home in the home healthcare industry. The company participated in a funding round for Medically Home, which raised $110 million in investment. This investment signifies Baxter's interest and support for at-home acute care services provided by Medically Home.

In May 2020, Fresenius Medical Care AG & Co. KGaA acquired the U.S.-based NxStage that allows company to provide patients with a wide choice of at-home treatment, and improve its offering for home dialysis in Europe, the Middle East, and Africa (EMEA) region.

In January 2022, Omron Healthcare Inc, a prominent key player in remote blood pressure monitoring and personal health technology launched its new remote patient monitoring services with its connected blood pressure monitors and an advanced mobile app designed to support patients and improve home treatment options.

Key Questions Answered in This Report:

• How has the global home healthcare market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global home healthcare market?
• What is the impact of each driver, restraint, and opportunity on the global home healthcare market?
• What are the key regional markets?
• Which countries represent the most attractive home healthcare market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the home healthcare market?
• What is the breakup of the market based on the service?
• Which is the most attractive service in the home healthcare market?
• What is the breakup of the market based on the indication?
• Which is the most attractive indication in the home healthcare market?
• What is the competitive structure of the global home healthcare market?
• Who are the key players/companies in the global home healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Home Healthcare Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Therapeutic Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Testing, Screening, and Monitoring Products
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Mobility Care Products
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Service

• 7.1 Skilled Nursing
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Rehabilitation Therapy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Hospice & Palliative Care
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Unskilled Care
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Respiratory Therapy
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Infusion Therapy
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Pregnancy Care
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by Indication

• 8.1 Cancer
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Respiratory Diseases
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Movement Disorders
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Cardiovascular Diseases & Hypertension
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Pregnancy
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Wound Care
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Diabetes
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast
• 8.8 Hearing Disorders
  • 8.8.1 Market Trends
  • 8.8.2 Market Forecast
• 8.9 Others
  • 8.9.1 Market Trends
  • 8.9.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 A&D Company Limited
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Addus HomeCare Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Amedisys Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 B. Braun Melsungen AG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Baxter International Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Becton Dickinson and Company
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Fresenius Medical Care AG & Co. KGaA
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Invacare Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Koninklijke Philips N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 McKesson Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Medline Industries LP
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 SWOT Analysis
  • 14.3.12 OMRON Healthcare Inc. (Omron Corporation)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 SWOT Analysis
  • 14.3.13 ResMed Inc.
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report